Page last updated: 2024-11-12

4,4,10-trimethyl-trans-decal-3-ol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

4,4,10-trimethyl-trans-decal-3-ol: specific 2,3-oxidosqualene-lanosterol cyclase inhibitor; RN given refers to (2alpha,4aalpha,8abeta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11127203
CHEMBL ID308982
SCHEMBL ID7107640
MeSH IDM0077905

Synonyms (25)

Synonym
CHEMBL308982 ,
TMD ,
4,4,10-trimethyl-trans-decal-3-ol
1,1,4a-trimethyl-decahydro-naphthalen-2-ol
(2s,4as,8ar)-1,1,4a-trimethyl-decahydro-naphthalen-2-ol
bdbm50003030
60761-10-6
7vm2yk5nyy ,
unii-7vm2yk5nyy
(2alpha,4aalpha,8abeta)-decahydro-1,1,4a-trimethyl-2-naphthalenol
SCHEMBL7107640
4,4,10beta-trimethyl-trans-decal-3beta-ol, (-)-
unii-6ook4clu1y
tmd l-form [mi]
58193-61-6
2-naphthalenol, decahydro-1,1,4a-trimethyl-, (2s,4as,8ar)-
tmd [mi]
2-naphthalenol, decahydro-1,1,4a-trimethyl-, (2r,4ar,8as)-rel-
4,4,10.beta.-trimethyl-trans-decal-3.beta.-ol, (+/-)-
4,4,10.beta.-trimethyl-trans-decal-3.beta.-ol
1,1,10-trimethyl-trans-2-decalol, (-)-
106949-60-4
4,4,10.beta.-trimethyl-trans-decal-3.beta.-ol, (-)-
1,1,10-trimethyl-trans-2-decalol
6OOK4CLU1Y ,
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Lanosterol synthase Rattus norvegicus (Norway rat)IC50 (µMol)9.00000.05304.52659.0000AID151662
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID151664Inhibitory activity against Oxidosqualene-lanosterol cyclase from Rat liver microsomes1996Journal of medicinal chemistry, Jun-07, Volume: 39, Issue:12
Structural and stereoelectronic requirements for the inhibition of mammalian 2,3-oxidosqualene cyclase by substituted isoquinoline derivatives.
AID86568Compound was tested for inhibition of cholesterol biosynthesis in HepG2 cells from [14C]- acetate1992Journal of medicinal chemistry, Sep-18, Volume: 35, Issue:19
N-(1-oxododecyl)-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclase.
AID151662Inhibitory activity against Oxidosqualene-lanosterol cyclase enzyme obtained from rat liver1992Journal of medicinal chemistry, Sep-18, Volume: 35, Issue:19
N-(1-oxododecyl)-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's4 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]